Cite
Effect of histologic subtype on treatment and outcomes for esophageal cancer in the United States.
MLA
Merkow, Ryan P., et al. “Effect of Histologic Subtype on Treatment and Outcomes for Esophageal Cancer in the United States.” Cancer (0008543X), vol. 118, no. 13, July 2012, pp. 3268–76. EBSCOhost, https://doi.org/10.1002/cncr.26608.
APA
Merkow, R. P., Bilimoria, K. Y., McCarter, M. D., Chow, W. B., Gordon, H. S., Stewart, A. K., Ko, C. Y., & Bentrem, D. J. (2012). Effect of histologic subtype on treatment and outcomes for esophageal cancer in the United States. Cancer (0008543X), 118(13), 3268–3276. https://doi.org/10.1002/cncr.26608
Chicago
Merkow, Ryan P., Karl Y. Bilimoria, Martin D. McCarter, Warren B. Chow, Howard S. Gordon, Andrew K. Stewart, Clifford Y. Ko, and David J. Bentrem. 2012. “Effect of Histologic Subtype on Treatment and Outcomes for Esophageal Cancer in the United States.” Cancer (0008543X) 118 (13): 3268–76. doi:10.1002/cncr.26608.